Overview

Desoximetasone Spray 0.05%, 0.25%; Dose Ranging Study

Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
The objectives of this study are to evaluate the efficacy and safety of two dosing regimens of desoximetasone 0.05% and 0.25% topical sprays as compared to a vehicle spray in patients with moderate to severe plaque psoriasis.
Phase:
Phase 2
Details
Lead Sponsor:
Taro Pharmaceuticals USA
Treatments:
Desoximetasone